Eucrates Biomedical Acquisition Corp.

Eucrates Biomedical Acquisition Corp. (Nasdaq: EUCR) is a blank-check company formed to pursue a merger or acquisition in the biomedical and life sciences sector. The company went public in 2021 and filed its annual report on Form 10-K with the SEC on April 11, 2022, accession number 0001410578-22-000855, reflecting its status as an active special purpose acquisition company conducting a search for a suitable target business within the healthcare and biomedical industry. As of the filing date, the company remained in the search phase, evaluating opportunities consistent with its sector focus. For complete filing history, ownership data, and deal-status tracking on EUCR and thousands of other SPACs, sign up for full access at SpacDesk.